FIRSTSUN CAPITAL BANCORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FIRSTSUN CAPITAL BANCORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $97.94M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $75.63M | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | $103.53M | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | $59.18M | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $43.16M | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | $47.59M | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | $20.50M | Mar 25, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $111.48M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $101.12M | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | $125.18M | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | $96.92M | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $113.11M | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | ($547.0K) | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | $3.90M | Mar 25, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.51M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $5.41M | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | $4.27M | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | $2.20M | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $3.46M | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | $6.16M | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | $6.91M | Mar 25, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.49B | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $8.10B | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | $7.88B | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | $7.43B | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $5.67B | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | $5.00B | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | $4.19B | Mar 25, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.33B | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $7.06B | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $7.00B | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $6.66B | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $5.14B | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $4.51B | Mar 25, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.15B | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $1.04B | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | $877.20M | Mar 6, 2026 |
| FY2025 | Dec 31, 2022 | $774.54M | Mar 6, 2026 |
| FY2024 | Dec 31, 2021 | $524.04M | Mar 7, 2025 |
| FY2023 | Dec 31, 2020 | $485.79M | Mar 7, 2024 |
| FY2022 | Dec 31, 2019 | $430.20M | Mar 16, 2023 |
| FY2021 | Dec 31, 2018 | $430.20M | Mar 25, 2022 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $93.48M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $93.48M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $93.48M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $93.48M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $33.05M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $33.05M | Mar 25, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $631.09M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $533.15M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $457.52M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $357.80M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $298.62M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $255.45M | Mar 25, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $652.59M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $615.92M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $479.36M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $343.53M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $668.46M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $201.98M | Mar 25, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Mar 25, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Mar 25, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 27.89M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | 27.71M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | 24.96M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | 24.92M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | 18.35M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | 18.32M | Mar 25, 2022 |